Scientific articles

15 Jul 2024

Differences in the cellular immune response during and after treatment of Sudanese patients with post-kala-azar dermal leishmaniasis, and possible implications for outcome

Journal of Epidemiology and Global Health

Scientific articles

15 Jul 2024

Enabling equitable and affordable access to novel therapeutics for pandemic preparedness and response via creative intellectual property agreements

Wellcome Open Research

Publications

11 Jul 2024

DNDi 2023 Annual Report

Scientific articles

2 Jul 2024

Design, conduct, analysis, and reporting of therapeutic efficacy studies in visceral leishmaniasis: A systematic review of published reports, 2000–2021

American Journal of Tropical Medicine and Hygiene

Publications

1 Jul 2024

2023 DNDi Financial Report

Press releases

1 Jul 2024

WHO recommends first all-oral treatment for acute sleeping sickness found in Eastern and Southern Africa

Press releases

24 Jun 2024

Paediatric malaria treatment developed in Brazil by not-for-profit organizations distributed to Indigenous children in the Amazon region

Scientific articles

20 Jun 2024

A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh

PLOS Neglected Tropical Diseases

Press releases

12 Jun 2024

New framework for visceral leishmaniasis elimination launched for Eastern Africa

Scientific articles

31 May 2024

Demystifying in vivo bioluminescence imaging of a Chagas disease mouse model for drug efficacy studies

Journal of Visualized Experiments

Videos

30 May 2024

Celebrating 20 Years of LEAP: Innovation and Impact

Statements

28 May 2024

DNDi interventions at the 77^th World Health Assembly